Operating Expenses: The sum of all operating expenses for the given industry.
Sio Gene Therapies Inc. (SIOX) had Operating Expenses of $71.56M for the most recently reported fiscal year, ending 2022-03-31.
Income Statement Financials | |
-- |
|
$-71.89M |
|
-- |
|
-- |
|
Operating Expenses |
$71.56M |
$-71.56M |
|
$-0.07M |
|
$-71.63M |
|
$-71.63M |
|
$-71.89M |
|
$-71.89M |
|
$-71.89M |
|
$-71.89M |
|
$-71.56M |
|
$-70.90M |
|
73.21M |
|
73.21M |
|
$-0.98 |
|
$-0.98 |
|
Balance Sheet Financials | |
$71.74M |
|
$0.90M |
|
$3.34M |
|
$75.08M |
|
$13.00M |
|
-- |
|
$1.73M |
|
$14.73M |
|
$60.35M |
|
$60.35M |
|
$60.35M |
|
73.74M |
|
Cash Flow Statement Financials | |
$-60.35M |
|
$3.65M |
|
$1.44M |
|
$120.17M |
|
$64.91M |
|
$-55.26M |
|
$7.42M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
5.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-61.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-119.12% |
|
-119.12% |
|
-95.75% |
|
-119.12% |
|
$0.82 |
|
$-0.83 |
|
$-0.82 |